Two industry groups, one representing health communicators and the other medical device makers, have sharply criticized a draft FDA guidance on how to present risk information in promotional materials.
Comparative drug info labeling helps doctors
September 15, 2009
5:22 pm
Stanford University researchers say that drug labeling would be much more informative for doctors and patients if it had to include comparative effectiveness information.
Until earlier this year, most drug manufacturers had been operating under the same policy relating to the use of sponsored links on search engines as had advertisers for other categories of products.
After widespread press coverage of “death panels” and boisterous August town halls, many Americans might well be wondering if it’s déjà vu all over again—will 2009 be a replay of 1994?
Strange how some bad ideas have a way of sticking around. Commercials in movie theaters, the cellophane they use to imprison DVDs and, in pharmaceutical marketing, online physician portals.
In its August 2009 blizzard of compliance correspondence, DDMAC used some of the harshest language in recent Warning Letter memory to send what can only be interpreted as a message that its patience is wearing thin.
Spectrum hires two in DC office
September 15, 2009
4:14 pm
Spectrum, a founding partner of GlobalHealthPR, an international communications network, added two new employees at its Washington DC headquarters.
Ferguson opens OTC specialty shop
September 15, 2009
4:10 pm
Feguson, a CommonHealth professional shop, launched a new “OTC Center of Excellence” focused on OTC marketing and promotion.
The day will come soon when all flu vaccines are grown in cell culture, using genetic splicing techniques to provoke and immunologic (antibody) response rather than growing actual viruses in hen eggs.